Skip to main content

Organon & Co.

OGN
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001821825

In the last 90 days, Organon & Co. insiders filed 0 open-market purchases and 1 sale; 636 institutions reported holding it in 13F filings for Q2 2026, worth $2.92B in total; no superinvestor holds it.

Members of Congress who traded OGN

Since 2020, newest trade first. Options and trades reported under an earlier ticker are included.

Trades
3
Filings
3
Members
3
Buys / sells
0 / 3
Estimated volume
$24.0K
Sum of range midpoints
Members of Congress who traded OGN
MemberTradesBuys / sellsEst. volumeLast tradedLast filed
Kevin HernRepublican · House · OK10 / 1$8.00KAug 5, 2026Aug 12, 2026
Gary C. PetersDemocrat · Senate · MI10 / 1$8.00KJul 10, 2025Nov 24, 2025
John W. HickenlooperDemocrat · Senate · CO10 / 1$8.00KJun 28, 2021Jul 9, 2021

Trades

Every reported trade in Organon & Co., newest filings first.

Congress trades
MemberAssetTypeOwnerTradedFiledDelayAmountSource
Kevin HernRepublican · House · OKOGNOrganon & Co. Common StockSellJointAug 5, 2026Aug 12, 2026Amended5 days$1K-$15KFiling
Gary C. PetersDemocrat · Senate · MIOGNOrganon & Co.Sell (full)SelfJul 10, 2025Nov 24, 2025137 daysLate$1K-$15KFiling
John W. HickenlooperDemocrat · Senate · COOGNOrganon & Co.Sell (full)SelfJun 28, 2021Jul 9, 202111 days$1K-$15KFiling

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.